Biocon Ltd. — Regulatory Filings 2020

Nov 3, 2020

==> picture [119 x 47] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

Date of submission: November 3, 2020

To	To
The Secretary	The Secretary
BSE Limited	National Stock Exchange of India Limited
Department of Corporate Services	Corporate Communication Department
Phiroze Jeejeebhoy Towers,	Exchange Plaza, Bandra Kurla Complex
Dalal Street,Mumbai – 400 001	Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol- BIOCON

Dear Sir/Madam,

Sub: Meetings conducted with Institutional Investors/Research Analysts.

Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor / Research Analysts:

DateName	Type of meeting	Location
November 2, 2020Capital Research Global InvestorsPSP Investments	TeleconferenceTeleconference	BangaloreBangalore

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

==> picture [77 x 81] intentionally omitted <==

For Biocon Limited

==> picture [78 x 30] intentionally omitted <==

---

Mayank Verma Company Secretary and Compliance Officer